sym.cmedu.bcst.md Open in urlscan Pro
2600:9000:24f1:2e00:1b:355a:52c0:93a1  Public Scan

Form analysis
1 forms found in the DOM

GET /search

<form id="sitesearch" action="/search" method="get">
  <input type="search" placeholder="Search for videos, people, news, and more..." name="q">
  <button class="access-hide" type="submit">Search</button>
</form>

Text Content

Skip to main content

   
 * person
 * Search


Search
 * close


 * person

 * Home
 * Topicschevron_right
   * chevron_leftTopics
   * Arthritis
   * Cancer
   * Cardiology
   * Diabetes
   * Diagnostic Medicine
   * Neurology
   * Prenatal Screening
   * Primary Care
   * Thrombosis
 * Submit A Question
 * About I Q&A

close




CGM EXPERT BOARDS MOVE BEYOND HBA1C TO APPLY TECHNOLOGY-BASED ADVANCES ACROSS
THE FULL SPECTRUM OF DIABETES CARE

View Symposium
Click Here to Download Late-Breaking Publications



Program Medium 
Internet-based program

Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity.
During the period March 6, 2024 through March 6, 2026, participants must 1) read
the learning objectives and faculty disclosures; 2) study the educational
activity, and are expected to view the activity, totaling 1.5 hours, to
successfully complete the activity and earn CME credit; 3) register and complete
the evaluation form and post-test; 4) score 100% on the post-test; and 5) print
out CME certificate.

Estimated Time to Complete Educational Activity
1.5 hours. Physicians must study the enduring activity, and are expected to view
every segment to successfully complete the activity and earn CME credit.

Course Overview
In this web-based program, physicians will learn how recent developments in
senor-based glucose monitoring have advanced the management of Type 2 and Type 1
diabetes.

Release Date
March 6, 2024

Expiration Date
March 6, 2026

Intended Audience
This complimentary CME educational activity is designed for all healthcare
providers (HCPs) involved in developing, delivering, consulting, and monitoring
care for patients with type 2 or type 1 diabetes, including endocrinologists,
diabetes specialists, family medicine specialists, primary care physicians,
physician associates, and related clinicians.

Registration
Participation in this activity is complimentary, and clinicians are invited to
view this CME-certified program and/or share this invitation with other
colleagues, departmental staff members, and healthcare professionals.

Grantor Support
This activity is supported by an independent medical education grant from Abbott
Diabetes Care.

Accreditation Statement
This activity has been planned and implemented in accordance with the
accreditation requirements and policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint providership of the
University of Massachusetts Chan Medical School and CMEducation Resources, LLC.
The University of Massachusetts Chan Medical School is accredited by the ACCME
to provide continuing medical education for physicians.

Credit Designation Statement
The University of Massachusetts Chan Medical School, Office of Continuing
Medical Education designates this enduring material for a maximum of 1.5 AMA PRA
Category 1 Credits(s)TM. Physicians should claim only the credit commensurate
with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure
It is the policy of the University of Massachusetts Chan Medical School to
ensure fair balance, independence, objectivity and scientific rigor in all
activities. All faculty participating in CME activities sponsored by the
University of Massachusetts Chan Medical School are required to present
evidence-based data, identify and reference off-label product use and disclose
all relevant financial relationships with those supporting the activity or
others whose products or services are discussed. Faculty disclosure will be
provided in the activity materials. 

Program Faculty and Disclosure

Program Faculty

Richard Bergenstal, MD – Program Chair
Executive Director
Park Nicollet International Diabetes Center
Adjunct Professor, Department of Medicine
University of Minnesota
St. Louis Park, MN

I have participated in clinical research, been a member of a scientific advisory
board, and served as a consultant for:  Abbott Diabetes Care, Ascensia, Bigfoot
Biomedical, Inc., CeQur, Dexcom, Eli Lilly, Embecta, Hygieia, Insulet,
Medtronic, Novo Nordisk, Onduo, Roche Diabetes Care, Sanofi and United
Healthcare, Vertex Pharmaceuticals and Zealand Pharma
My institution receives NIH/NIDDK and PCORI funding

Jennifer L. Sherr, MD, PhD
Professor of Pediatrics, Pediatric Endocrinology 
Yale University School of Medicine
New Haven, CT

Research Contracts: Abbott Diabetes, JDRF, Insulet, Medtronic, NIH, Provention
Bio
Consulting: Abbott Diabetes, Insulet, Medtronic, Zealand
Advisory Boards: Cecelia Health, Insulet Corporation, Mannkind, Medtronic
Diabetes, Startup Health Diabetes Moonshot, and Vertex

Medha Munshi, MD
Director of Joslin Geriatric Diabetes Programs
Geriatrician, Beth Israel Deaconess Medical Center
Associate Professor of Medicine, Harvard Medical School
Brookline, MA

Consultant: Sanofi , Medtronic

Program Managers and Web Editor Disclosure 
Program Managers Gideon Bosker, MD and Denise Leary have nothing to disclose.

Educational Objectives

Upon completion of this activity, participants will be able to:

 * Outline and discuss the evidentiary basis for senor/patch-based CGM
   technologies, and how to best Implement CGM-based technologies into their
   overall diabetes care plans for patients with T1D and T2D.
 * Analyze the rationale and evidence for recommending and facilitating adoption
   of technology-centric CGM monitoring and treatment plans using
   patch-and-reader-based technologies.
 * Compare and contrast available CGM-facilitating monitoring technologies and
   pair such technologies with optimal patient profiles.
 * Educate patients with diabetes about the rationale, evidence, and outcome-
   optimizing results associated with technology-based, patient-centric and
   physician-directed CGM monitoring strategies that can be used to effect
   optimal lifestyle, diet-, and pharmacology-based approaches to attaining
   guideline-based HA1c levels in patients with T1D and T2D.
 * Identify which patients with diabetes are ideal candidates for a
   technology-based, patient-directed glucose monitoring system.
 * Interpret and apply data and results from clinical trials and experts with
   experience in CGM-facilitating monitoring technologies to improve patient
   care, improve safety of drug therapy for T1D and T2D, detect and mitigate
   risk of hypoglycemia, improve patient- and physician-directed changes in
   antidiabetic therapy, reinforce the safe use of antidiabetic drugs, and
   facilitate patient-activated drug titration, glycemic monitoring and disease
   management.
 * Translate landmark clinical studies focused on CGM-based technologies to the
   front lines of clinical practice in the diabetes and primary care setting;
   and understand the translational implications of deploying sensor-based,
   CGM-based technologies as a foundational approach to improving outcomes in
   patients across the spectrum of diabetes.
 * Educate other clinical providers on the diabetes care team about the
   rationale, role, evidence, and outcome-enhancing results that are derived
   from employing technology-based CGM strategies—both patient- and
   physician-directed—across the broad spectrum of patients with diabetes


Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer
that has active, ongoing internet access for the duration of the program, as
well as a compatible Flash-viewer. An email address is required for
registration, and a printer is required to print out the CME certificate.

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask
you for your name, degree, affiliation, street address, telephone number, fax
number, and/or e-mail address (the "Information"). We use that Information in
the following ways:

 * We use the Information to grade your post-test and to send you a certificate
   of completion of the CME activity. If we use a third-party company to grade
   your post-test and issue certificates of completion, we will give the
   Information to that company for that purpose only.
 * For each CME activity that you take, you must complete an evaluation
   questionnaire. That questionnaire asks if you are willing to participate in a
   follow-up survey. If you answer yes, we will use your name and contact
   information to send you the survey.
 * We may use the Information to send you information about other CME activities
   that CMEducation Resources is offering.
 * If our company is acquired by or merged into another company, we may make the
   Information available to the new owner/entity to use in the ways described
   above, to enable it to continue our business.
 * You should check this privacy policy periodically to see whether we have made
   any changes.


Disclaimer

Copyright © 2024 by CMEducation Resources, LLC All rights reserved. 

Reproduction, distribution, or translation without express written permission is
strictly prohibited. 

Content on this webcast reflects the opinions, output, and analyses of experts,
investigators, educators, and clinicians whose activities for, while
independent, are commercially supported by the sponsor noted at the start of
each activity. 

Content on this webcast is not meant to be, nor substitute for national
guidelines or recommendations generated by professional, academic societies,
colleges, or associations. 

View Symposium



Disclaimer:
Copyright © 2024 by CMEducation Resources, LLC All rights reserved. Content on
this webcast reflects the opinions, output, and analyses of experts,
investigators, educators, and clinicians whose activities for, while
independent, are commercially supported by the sponsor noted at the start of
each activity.
Content on this webcast is not meant to be, nor substitute for national
guidelines or recommendations generated by professional, academic societies,
colleges, or associations.
Content on this webcast is intended for educational value only. Its contents,
analyses, and any recommendation made herein are intended to make scientific
information and opinion available to health professionals, to stimulate thought,
and further investigation. This webcast is not designed nor is any aspect of the
contents here intended to provide advice regarding medical diagnosis or
treatment for any individual case. Any decisions regarding diagnosis and/or
management of any individual patient or group of patients should be made on
individual basis after having consulted appropriate sources, whether they be
appropriate consultants and/or guidelines and recommendations issued by national
organizations, professional societies, governmental health organizations, or
similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of CMEducation Resources,
LLC, program supporters or accreditors, but reflect the opinions and analyses of
the experts who have authored the material. Mention of products or services does
not constitute endorsement. Clinical, legal, financial, and other comments are
offered for general guidance only; and professional counsel should be sought for
all specific situations.

Clinical Webcasts®

Powered by BROADCASTMED